Talat Mokhtari Azad

Dr. Talat Mokhtari Azad


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Science of The Total Environment
Verified
Journal Article
Closed access
Sasan FaridiSasan Faridi
Sasan Faridi
SNSadegh Niazi
Sadegh Niazi
KSKaveh Sadeghi
Kaveh Sadeghi
KNKazem Naddafi
Kazem Naddafi
JYJila Yavarian
Jila Yavarian
TATalat Mokhtari Azad
Talat Mokhtari Azad

24 September 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HHHamidreza Hashemi
Hamidreza Hashemi
SPSomayeh Pouyanfard
Somayeh Pouyanfard
MBMOJGAN BANDEHPOUR
MOJGAN BANDEHPOUR
ZNZahra Noroozbabaei
Zahra Noroozbabaei
BKBahram Kazemi
Bahram Kazemi
TATalat Mokhtari Azad
Talat Mokhtari Azad
Considering the emergence of highly pathogenic influenza viruses and threat of worldwide pandemics, there is an urgent need to develop broadly-protective influenza vaccines. In this study, we demonstrate the potential of T7 bacteriophage-based nanoparticles with genetically fused ectodomain of influenza A virus M2 protein (T7-M2e) as a candidate universal flu vaccine. Immunization of mice with non-adjuvanted T7-M2e elicited M2e-specific serum antibody responses that were similar in magnitude to those elicited by M2e peptide administered in Freund’s adjuvant. Comparable IgG responses directed against T7 phage capsomers were induced following vaccination with wild type T7 or T7-M2e. T7-M2e immunization induced balanced amounts of IgG1 and IgG2a antibodies and these antibodies specifically recognized native M2 on the surface of influenza A virus-infected mammalian cells. The frequency of IFN-γ-secreting T cells induced by T7-M2e nanoparticles was comparable to those elicited by M2e peptide emulsified in Freund’s adjuvant. Emulsification of T7-M2e nanoparticles in Freund’s adjuvant, however, induced a significantly stronger T cell response. Furthermore, T7-M2e-immunized mice were protected against lethal challenge with an H1N1 or an H3N2 virus, implying the induction of hetero-subtypic immunity in our mouse model. T7-M2e-immunized mice displayed considerable weight loss and had significantly reduced viral load in their lungs compared to controls. We conclude that display of M2e on the surface of T7 phage nanoparticles offers an efficient and economical opportunity to induce cross-protective M2e-based immunity against influenza A.

28 April 2011 in Infectious Agents and Cancer
Verified
Journal Article
Open access
PDF file
SJSomayeh Jalilvand
Somayeh Jalilvand
ZSZabihollah Shoja
Zabihollah Shoja
TATalat Mokhtari Azad
Talat Mokhtari Azad
RNRakhshandeh Nategh
Rakhshandeh Nategh
AGAhmad Gharehbaghian
Ahmad Gharehbaghian
Seroepidemiological surveys show that the prevalence of human herpesvirus 8 (HHV-8) infection mostly varies in various geographical areas and reflects the local incidence of classic and endemic KS, being widespread in sub-Saharan Africa and Mediterranean countries and uncommon in the USA and Northern Europe. In the Middle East only few populations, such as Ashkenazi and Sephardic groups in Israel, have been adequately evaluated for HHV-8 seroprevalence. Among Iranian population a striking higher seroprevalence of HHV8 has been reported among haemodialysis (16.9%), renal transplant recipients (25%) and HIV (45.7%) patients compared to blood donors (2%). Kaposi's sarcoma (KS) is the rarest cancer in Iran, with an annual age-standardized incidence varying from 0.10 to 0.17 per 100,000 in males and from 0.06 to 0.08 per 100,000 in females. KS, however, is one of the most important malignancies in Iranian renal transplanted patients affecting up to 2.4% of organ recipients. The epidemiology of HHV8 and KS in Iran needs further evaluation. While the high prevalence of HHV-8 antibodies in HIV positive and haemodialysis individuals may be attributed to high-risk sexual behavior and polytransfusions, respectively, unknown determinants may be responsible for high seroprevalence of HHV8 and high incidence of KS in solid organ recipients. A global survey on HHV8 seroprevalence in Iran is mandatory to define co-factors associated with HHV8 infection and KS risk in the general Iranian population and in specific patient groups.

7 October 2019 in Virology Journal
Verified
Journal Article
Open access
PDF file
MFMahdieh Farzanehpour
Mahdieh Farzanehpour
SMSayed-Hamidreza Mozhgani
Sayed-Hamidreza Mozhgani
SJSomayeh Jalilvand
Somayeh Jalilvand
EFEbrahim Faghihloo
Ebrahim Faghihloo
SASetareh Akhavan
Setareh Akhavan
TATalat Mokhtari Azad
Talat Mokhtari Azad
Background: Finding new biomarkers for the early detection of cervical cancer is an essential requirement in this field. In this study, we aimed to evaluate the expression level of potential biomarkers in progression of cervical cancer in patients with cervical cancer compared to normal subjects.Methods: The expression levels of tissue and serum miRNAs, including miR-9, miR-192 and miR-205, were investigated in 36 normal, 18 precancer, and 18 cervical cancer samples using real-time polymerase chain reaction.Results: The results showed the higher significant expressions of miR-9, miR-192 and miR-205 in the tissue of cancer samples than those in the normal samples. Moreover, the miR-192 and miR-205 expression were significantly increased in the cancer group in comparison with the precancer group. Examination of serum samples revealed the increase in the expression level in the cancer groups than in the normal samples, for miR-9, miR-192 and miR-205 and the expressions of miR-9, miR-192 and miR-205 were significantly up-regulated in the precancer group in comparison with the normal group. Also the expression of miR-205 was remarkably increased in the cancer group in comparison with the precancer group. The receiver operating characteristic (ROC) analyses showed the highest area under the curve value for miR-192.Conclusions: Given the increased expression level of miR-192 in cancer and in precancerous tissue and serum compared with the normal tissue and serum validated by analysing the ROC curve, miR-192 can be used as potential biomarker for the early detection of cervical cancer.

2 May 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JYJila Yavarian
Jila Yavarian
ANAhmad Nejati
Ahmad Nejati
VSVahid Salimi
Vahid Salimi
NJNazanin Zahra Shafiei Jandaghi
Nazanin Zahra Shafiei Jandaghi
KSKaveh Sadeghi
Kaveh Sadeghi
TATalat Mokhtari Azad
Talat Mokhtari Azad
Purpose: Whole genome sequencing of SARS-CoV2 is important to find useful information about the viral lineages, variants of interests and variants of concern. As there are not enough data about the circulating SARS-CoV2 variants in Iran, we sequenced 54 SARS-CoV2 genomes during the 5 waves of pandemic in Iran. Methods: After viral RNA extraction from clinical samples collected during the COVID-19 pandemic, next generation sequencing was performed using the Nextseq platform. The sequencing data were analyzed and compared with reference sequences. Results: During the 1st wave, V and L clades were detected. The second wave was recognized by G, GH and GR clades. Circulating clades during the 3rd wave were GH and GR. In the fourth wave GRY (alpha variant), GK (delta variant) and one GH clade (beta variant) were detected. All viruses in the fifth wave were in clade GK (delta variant). There were different mutations in all parts of the genomes but Spike-D614G, NSP12-P323L, N-R203K and N-G204R were the most frequent mutants in these studied viruses. Conclusions: These findings display the significance of SARS-CoV2 monitoring to help on time detection of possible variants for pandemic control and vaccination plans.

9 August 2020 in Iranian Journal of Public Health
Verified
Journal Article
Open access
PDF file
JYJila Yavarian
Jila Yavarian
NSNazanin-Zahra Shafiei-Jandaghi
Nazanin-Zahra Shafiei-Jandaghi
KSKaveh Sadeghi
Kaveh Sadeghi
SMSomayeh Shatizadeh Malekshahi
Somayeh Shatizadeh Malekshahi
VSVahid Salimi
Vahid Salimi
TATalat Mokhtari Azad
Talat Mokhtari Azad
In Jan 2020, the outbreak of the 2019 novel coronavirus (SARS-CoV-2) in Wuhan, Hubei Province of China spread increasingly to other countries worldwide which WHO declared it as a public health emergency of international concern. Iran was included in the affected countries. Throat swab specimens were collected and tested by using real-time reverse transcription PCR (RT-PCR) kit targeting the E region for screening and RNA dependent RNA polymerase for confirmation. Conventional RT-PCR was conducted for the N region and the PCR products were sequenced by Sanger sequencing. The first seven cases of SARS-CoV-2 infections were identified in Qom, Iran. This report describes the clinical and epidemiological features of the first cases of SARS-CoV-2 confirmed in Iran. Future research should focus on finding the routes of transmission for this virus, including the possibility of transmission from foreign tourists to identify the possible origin of SARS-CoV-2 outbreak in Iran.